ClinVar Miner

Submissions for variant NM_000251.2(MSH2):c.1662-10C>T (rs752606387)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001083456 SCV000559186 likely benign Hereditary nonpolyposis colorectal neoplasms 2020-11-25 criteria provided, single submitter clinical testing
Color Health, Inc RCV000580913 SCV000684960 likely benign Hereditary cancer-predisposing syndrome 2016-04-26 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000590414 SCV000696221 uncertain significance not provided 2017-06-05 criteria provided, single submitter clinical testing Variant summary: The MSH2 c.1662-10C>T variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in ExAC and the literature in 33/118436 control chromosomes at a frequency of 0.0002786, which does not exceed the estimated maximal expected allele frequency of a pathogenic MSH2 variant (0.0005683). However, one publication reported that the variant is a common polymorphism in black South African controls (frequency = 0.34) suggesting the variant is benign (Davison_Dissertation_2012). In addition, one clinical diagnostic laboratory has classified this variant as likely benign. Taken together, this variant is classified as VUS-possibly benign.
GeneDx RCV000590414 SCV001745401 benign not provided 2015-03-27 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine,Sinai Health System RCV000590414 SCV001552910 likely benign not provided no assertion criteria provided clinical testing The MSH2 c.1662-10C>T variant was not identified in the literature nor was it identified in the UMD-LSDB, database. The variant was identified in dbSNP (ID: rs752606387) as "With Uncertain significance allele", ClinVar (classified as likely benign by Invitae and Color Genomics; classified as uncertain significance by Integrated Genetics/Laboratory Corporation of America). The variant was identified by our laboratory in a patient with breast cancer under the age of 30 and a co-occurring BRCA1 pathogenic variant (BRCA1, c.1100del). The variant was identified in control databases in 7 of 276086 chromosomes at a frequency of 0.000025 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 1 of 23982 chromosomes (freq: 0.00004), European Non-Finnish in 5 of 126050 chromosomes (freq: 0.00004), and South Asian in 1 of 30530 chromosomes (freq: 0.00003), while the variant was not observed in the Other, Latino, Ashkenazi Jewish, East Asian, or European Finnish populations. The variant occurs outside of the splicing consensus sequence and 0 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. The MSH2 c.1662-10C nucleotide is not conserved in mammals and a C>T substitution is observed in several species. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.